BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37738316)

  • 1. Taxane-Based Chemotherapy Is Effective in Metastatic Appendiceal Adenocarcinoma.
    Dansby J; More A; Zeineddine M; Yousef A; Bent A; Dayyani F; Wolff R; Overman M; Shen JP
    Oncologist; 2023 Dec; 28(12):e1303-e1305. PubMed ID: 37738316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taxane-based Chemotherapy is Effective in Metastatic Appendiceal Adenocarcinoma.
    Dansby J; More A; Zeineddine M; Yousef A; Bent A; Dayyani F; Wolff R; Overman M; Shen JP
    medRxiv; 2023 Jul; ():. PubMed ID: 37502847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer.
    Tejani MA; ter Veer A; Milne D; Ottesen R; Bekaii-Saab T; Benson AB; Schrag D; Shibata S; Skibber J; Weiser M; Wilkinson N; Cohen SJ
    J Natl Compr Canc Netw; 2014 Aug; 12(8):1123-30. PubMed ID: 25099444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.
    Antonarakis ES; Lu C; Luber B; Wang H; Chen Y; Nakazawa M; Nadal R; Paller CJ; Denmeade SR; Carducci MA; Eisenberger MA; Luo J
    JAMA Oncol; 2015 Aug; 1(5):582-91. PubMed ID: 26181238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover Trial.
    Shen JP; Yousef AM; Zeineddine FA; Zeineddine MA; Tidwell RS; Beaty KA; Scofield LC; Rafeeq S; Hornstein N; Lano E; Eng C; Matamoros A; Foo WC; Uppal A; Scally C; Mansfield P; Taggart M; Raghav KP; Overman MJ; Fournier K
    JAMA Netw Open; 2023 Jun; 6(6):e2316161. PubMed ID: 37261831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Analysis of Taxane-Based Therapy in Small Bowel Adenocarcinoma.
    Aldrich JD; Raghav KPS; Varadhachary GR; Wolff RA; Overman MJ
    Oncologist; 2019 Jun; 24(6):e384-e386. PubMed ID: 30598498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach.
    Schmalenberg H; Al-Batran SE; Pauligk C; Zander T; Reichart A; Lindig U; Kleiß M; Müller L; Bolling C; Seufferlein T; Reichardt P; Kullmann F; Eschenburg H; Schmittel A; Egger M; Block A; Goetze TO
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):559-569. PubMed ID: 29285668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanes.
    Kucukoztas N; Oguz A; Rahatli S; Altundag O; Altundag K
    J BUON; 2016; 21(5):1076-1081. PubMed ID: 27837607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-operative chemotherapy improves the survival of patients with well differentiated widespread metastatic appendiceal non-mucinous adenocarcinomas.
    Yu T; Fan H; Lv Q; Li J; Wei L; Wang M; Dong J; Cai X
    Ann Palliat Med; 2021 May; 10(5):5156-5170. PubMed ID: 34044560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial.
    Glockzin G; Rochon J; Arnold D; Lang SA; Klebl F; Zeman F; Koller M; Schlitt HJ; Piso P
    BMC Cancer; 2013 Feb; 13():67. PubMed ID: 23391248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery.
    Uemura M; Qiao W; Fournier K; Morris J; Mansfield P; Eng C; Royal RE; Wolff RA; Raghav K; Mann GN; Overman MJ
    BMC Cancer; 2017 May; 17(1):331. PubMed ID: 28506255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer.
    Raghav K; Shen JP; Jácome AA; Guerra JL; Scally CP; Taggart MW; Foo WC; Matamoros A; Shaw KR; Fournier K; Overman MJ; Eng C
    Br J Cancer; 2020 Oct; 123(8):1262-1270. PubMed ID: 32733093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
    Thuss-Patience PC; Shah MA; Ohtsu A; Van Cutsem E; Ajani JA; Castro H; Mansoor W; Chung HC; Bodoky G; Shitara K; Phillips GDL; van der Horst T; Harle-Yge ML; Althaus BL; Kang YK
    Lancet Oncol; 2017 May; 18(5):640-653. PubMed ID: 28343975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological features and prognosis of primary appendiceal adenocarcinoma].
    Liang JW; Wang Z; Zhou ZX; Zhang XM; Hu JJ; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):616-9. PubMed ID: 23158998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxane-based Combination Therapies for Metastatic Prostate Cancer.
    Corn PG; Agarwal N; Araujo JC; Sonpavde G
    Eur Urol Focus; 2019 May; 5(3):369-380. PubMed ID: 29275145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line Chemotherapy for Previously Treated Metastatic Small Bowel Adenocarcinoma: A Retrospective Analysis.
    Nakazawa T; Narita Y; Kumanishi R; Ogata T; Matsubara Y; Nozawa K; Kato K; Honda K; Masuishi T; Bando H; Kadowaki S; Ando M; Hara K; Tajika M; Muro K
    Anticancer Res; 2021 Oct; 41(10):5147-5155. PubMed ID: 34593466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage chemotherapy with irinotecan and cisplatin in patients with metastatic gastric cancer failing both 5-fluorouracil and taxanes.
    Park SH; Choi EY; Bang SM; Cho EK; Lee JH; Shin DB; Ki Lee W; Chung M
    Anticancer Drugs; 2005 Jul; 16(6):621-5. PubMed ID: 15930889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.
    Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ
    Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis.
    Wagner PL; Jones D; Aronova A; Shia J; Weiser MR; Temple LK; Chung KY; O'Reilly EM; Kelsen D; Paty PB; Nash GM
    Dis Colon Rectum; 2012 Apr; 55(4):407-15. PubMed ID: 22426264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial.
    Gitlitz BJ; Tsao-Wei DD; Groshen S; Davies A; Koczywas M; Belani CP; Argiris A; Ramalingam S; Vokes EE; Edelman M; Hoffman P; Ballas MS; Liu SV; Gandara DR
    J Thorac Oncol; 2012 Mar; 7(3):574-8. PubMed ID: 22198425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.